Bailey Glasser Lawyers Author Chambers & Partners Global Guide M&A Chapter

Nicholas S. Johnson, Jonathan S. Deem, Jennifer S. Fahey, and Japera A. Parker share insights into the state of M&A in Washington, D.C.

Continue reading

Bailey Glasser partners Nicholas S. Johnson, Jonathan S. Deem, Jennifer S. Fahey, and lawyer Japera A. Parker have authored an article appearing in the Chambers and Partners 2026 Corporate M&A Global Practice Guide: Trends and Developments, USA – Washington, D.C.: “Structuring M&A Deals Around Regulatory Uncertainty and Delay in Washington, DC: A Practical Legal Guide.”

In this article, the authors examine ways that the regulatory environment facing deal makers today is structurally more complex than it was even a decade ago, caused most recently in part due to changes triggered by federal agencies in Washington, D.C. As set forth in the introduction:

The United States, the Federal Trade Commission (FTC) and Department of Justice Antitrust Division have pursued increasingly aggressive merger enforcement strategies. The Committee on Foreign Investment in the United States (CFIUS) has expanded its jurisdictional reach following the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA). The European Commission continues to refine its framework under the EU Merger Regulation, including its new tools under the Foreign Subsidies Regulation. Sector-specific regulators – from the Federal Communications Commission to the Federal Energy Regulatory Commission to banking supervisors – layer additional review timelines and substantive requirements atop general competition review. Meanwhile, multi-jurisdictional deals increasingly face parallel reviews across dozens of antitrust regimes worldwide, each with its own substantive standards, procedural timelines and political dynamics.

Against this backdrop, sophisticated M&A counsel must approach deal structuring not merely as a legal exercise in documentation, but as a strategic exercise in risk allocation.

Read more at this link.

July 11 is the Bailey Glasser Boise Twilight Criterium

This is our fifth year as title sponsor of this elite race.

Continue reading

We’re the proud title sponsor of the Bailey Glasser Boise Twilight Criterium, one of the most iconic criterium races in the nation taking place in Boise, Idaho on July 11, 2026. This is Bailey Glasser’s fifth year being the title sponsor, and it’s the 39th year of this race, a cornerstone of the American Criterium Cup (ACC), the premier six‑race professional criterium series in the United States.

Boise proudly serves as the fourth stop on the 2026 national tour, with the country’s top professional men and women descending on Idaho’s capital to battle for critical ACC points and a share of a $500,000 total prize purse, split evenly between the women’s and men’s fields.

“This is the fifth year our law firm of Bailey & Glasser, LLP is sponsoring an event that captures the unique spirit and freedom of Boise,” said Ben Schwartzman, Bailey Glasser’s Boise managing partner and Boise native. “Sir Conan Arthur Doyle famously said: ‘When the spirits are low, when the day appears dark, when work becomes monotonous, when hope hardly seems worth having, just mount a bicycle and go out for a spin down the road, without thought on anything but the ride you are taking.’ We look forward to taking a spin with our local and national riders here in Boise in July. Hail Boise!”

Learn more here.

Bailey Glasser client Phillip Dressel and Mass Torts Practice Group Leader David L. Selby are featured in the The Wall Street Journal: “The Cancer Victims Who Could Sink Bayer’s Roundup Settlement.” To read the full article, visit this gift link.

This article describes the current landscape of lawsuits involving Bayer’s Roundup weedkiller. On February 17, 2026 “Monsanto announced a proposed U.S. nationwide class settlement designed to resolve current and future Roundup™ claims alleging Non-Hodgkin Lymphoma (NHL) injuries through a long-terms claims program.” Under the terms of the proposed class settlement, claimants can choose whether they want to opt-out of the class settlement.

Bailey Glasser did not object to the class settlement and takes the position that the decision of whether claimants should participate in the class settlement or opt-out is a client centric decision and one which should be made by each individual client. Bailey Glasser is not opposed to the class settlement and acknowledges they will have clients that choose to participate in the class settlement and some that will not. Moreover, Bailey Glasser is not attempting to sink Bayer’s Roundup Settlement but simply opting out certain clients, including those cases already set for trial.

Mr. Dressel is one of the clients that has decided to not participate in the class settlement. Mr. Dressel is a landscaper who used Roundup. In 2023 he noticed lesions on his arms, and sometime thereafter was diagnosed with cancer. Since then, he has had many medical procedures, including having his left leg amputated and a tumor removed from his skull. Given his extensive pain and suffering, and shortened life expectancy, it is our position that Mr. Dressel cannot be adequately compensated under the existing terms of the class settlement. As noted in the WSJ article: David Selby II, one of the attorneys who represents Mr. Dressel, said we are “working to get him a trial as soon as possible.”

Bailey & Glasser is a national law firm leading litigation against companies like Monsanto.

Twelve Bailey Glasser partners were named to the 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers guide. Our 2026 recipients are John W. Barrett; Mark G. Boyko; Katherine E. Charonko; Brian A. Glasser; Joshua I. Hammack; James L. Kauffman; Lawrence “Larry” Lederer; Jonathan R. Marshall; D. Todd Mathews; Michael L. Murphy; Gregory Y. Porter; and David L. Selby II.

Lawdragon’s announcement states:

We’re honored to recognize The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers.

These amazing advocates find pathways to justice for investors who have been defrauded, companies who have been blocked from fair competition and consumers who have been duped, hornswoggled and otherwise had their rights trampled on by ruthless corporations, from social media to pharmaceuticals.

This is our 9th edition reporting on leading lights of the plaintiff financial bar. This guide and the practices it represents have grown exponentially since 2007, when we first published a guide to plaintiff lawyers. Resumed in 2019, it reflects the astounding scale of wealth and, some would say, greed that permeates big business.

Year by year, the accomplishments of these lawyers astound in both the sheer size of the financial compensation they achieve and in the perseverance and legal skill required to succeed in these cases.

View the full 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers announcement and list here.

Meet this year’s recipients at this link.

Bailey Glasser Mass Torts Practice Group Leader David L. Selby II was quoted in a Wall Street Journal article about the ongoing talc litigation with Johnson & Johnson and a Thursday ruling that the law firm of Beasley Allen was disqualified from representing talc plaintiffs moving forward. Beasley Allen will appeal.

David Selby commented that “[i]f the ruling were to stand, then all these women would have to seek new counsel,” he said. “It delays trials. It does nothing but work in favor of J&J.”

Read the article here.